This could be the case when GC-specific codeletion of Crebbp/Kmt2d is introduced in the FL-prone Bcl2-transgenic background, recapitulating the genetic makeup of FL/tFL and DLBCL. Here, BCL2 is linked to diffuse large B-cell lymphoma.